☆ 4.6 Letter

Clinically Probable Multiple System Atrophy with Predominant Parkinsonism Associated with Myotonic Dystrophy Type 2

MOVEMENT DISORDERS (2009)

期刊

MOVEMENT DISORDERS

卷 24, 期 9, 页码 1407-1409

出版社

WILEY-LISS

DOI: 10.1002/mds.22625

关键词

-

类别

Clinical Neurology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Targeting Myotonic Dystrophy Type 1 with Metformin

Mikel Garcia-Puga, Ander Saenz-Antonanzas, Ander Matheu, Adolfo Lopez de Munain

Summary: Myotonic dystrophy type 1 (DM1) is a genetic multisystemic disorder resembling accelerated aging, for which there is currently no cure. However, recent studies have shown that metformin, an antidiabetic drug, may provide a novel therapy to combat DM1 and is linked with aging.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2

Lubov Timchenko

Summary: Myotonic Dystrophies type 1 (DM1) and type 2 (DM2) are complex multisystem diseases without disease-based therapies. DM1 is associated with the toxicity of RNA CUG repeats, leading to disturbances in RNA metabolism. The pathogenesis of DM2 is not fully understood. Progress has been made in translating mechanistic knowledge in DM1 and DM2 to clinical trials, focusing on the development of disease-specific therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Biology

The hallmarks of myotonic dystrophy type 1 muscle dysfunction

Lauren L. Ozimski, Maria Sabater-Arcis, Ariadna Bargiela, Ruben Artero

Summary: Myotonic dystrophy type 1 (DM1) is the most prevalent form of muscular dystrophy in adults with no current treatment options. The disease is mainly characterised by muscle pathology and affects patients worldwide. Research into various pathways affected in DM1 may provide new therapeutic targets.

BIOLOGICAL REVIEWS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Modeling Myotonic Dystrophy Type 2 Using Drosophila melanogaster

Marta Marzullo, Sonia Coni, Assia De Simone, Gianluca Canettieri, Laura Ciapponi

Summary: This article introduces the principal tools used in Drosophila to study and dissect molecular pathways related to muscular dystrophies and summarizes the main findings in DM2 pathogenesis based on DM2 Drosophila models. It also illustrates how Drosophila can be successfully used to generate a tractable animal model to identify novel genes and potential drugs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials

Matteo Garibaldi, Tommaso Nicoletti, Elisabetta Bucci, Laura Fionda, Luca Leonardi, Stefania Morino, Laura Tufano, Girolamo Alfieri, Antonio Lauletta, Gioia Merlonghi, Alessia Perna, Salvatore Rossi, Enzo Ricci, Jorge Alonso Perez, Tommaso Tartaglione, Antonio Petrucci, Elena Maria Pennisi, Marco Salvetti, Gary Cutter, Jordi Diaz-Manera, Gabriella Silvestri, Giovanni Antonini

Summary: In a large cohort of DM1 patients, muscle involvement was characterized by fat replacement, muscle atrophy and STIR positivity, which correlated with disease severity and duration. The study also identified STIR hyperintensity as an early marker of muscle involvement, providing potential therapeutic targets for future clinical trials.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Review Clinical Neurology

The current clinical perception of myotonic dystrophy type 2

Felix Kleefeld, Benedikt Schoser

Summary: DM2 is a genetic disorder characterized by progressive muscle weakness, wasting, and muscle pain, and it can also affect other organ systems. This review provides an updated overview on the research literature on DM2, with a focus on the management of multisystemic involvement and atypical clinical phenotypes.

CURRENT OPINION IN NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Polysomnographic findings of myotonic dystrophy type 1/type 2: evidence from case-control studies

Ye Zhang, Rong Ren, Linghui Yang, Hui Jin, Yuru Nie, Haipeng Zhang, Yuan Shi, Larry D. Sanford, Michael V. Vitiello, Xiangdong Tang

Summary: This study explores the differences in polysomnographic and multiple sleep latency test (MSLT) between myotonic dystrophy type 1/type 2 (DM1/DM2) patients and controls. The results reveal significant abnormalities in the polysomnographic sleep of DM1 patients, while differences in polysomnographic sleep change between DM2 patients and controls could not be established due to limited studies.

SLEEP (2023)

添加到收藏夹

Article Clinical Neurology

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2

Stojan Peric, Jelena Zlatar, Luka Nikolic, Vukan Ivanovic, Jovan Pesovic, Ivana Petrovic Djordjevic, Svetlana Sreckovic, Dusanka Savic-Pavicevic, Giovanni Meola, Vidosava Rakocevic-Stojanovic

Summary: This study aimed to analyze the frequency and type of autoimmune diseases (AIDs) in patients with DM2 from the Serbian DM registry. The results showed that AIDs were present in as high as 30% of DM2 patients, with a significantly higher percentage of women among patients with AIDs. Therefore, screening for AIDs in DM2 patients seems reasonable.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1

Thiery De Serres-Berard, Siham Ait Benichou, Dominic Jauvin, Mohamed Boutjdir, Jack Puymirat, Mohamed Chahine

Summary: DM1 is a dominant genetic disease that can be treated by altering the chemical design of antisense oligonucleotides. Various strategies involving chemical modifications and conjugation with specific functional molecules have been shown to improve the potency in muscle and cardiac tissues. In addition, intrathecal administration can be used to treat central nervous system defects in DM1.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Clinical Neurology

Afterdischarges in myotonic dystrophy type 1

Li Yang, Xiuying Chen, Rui Wu

Summary: Afterdischarges may be present in DM1 patients during electrodiagnostic testing. A study comparing DM1 and non-DM1 myotonia patients found afterdischarges to be prevalent in DM1 patients, but absent in non-DM1 myotonia patients. Therefore, afterdischarges may serve as a clinical indicator for DM1 diagnosis.

NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

Gender effect on cardiac involvement in myotonic dystrophy type 1

Matteo Garibaldi, Antonio Lauletta, Elisabetta Bucci, Laura Fionda, Fiammetta Vanoli, Luca Leonardi, Girolamo Alfieri, Laura Tufano, Stefania Morino, Gioia Merlonghi, Paolo Anibaldi, Marco Salvetti, Marco Testa, Giovanni Antonini

Summary: The risk of cardiac conduction abnormalities in DM1 is significantly higher in males than females, while there is no significant gender difference in overall CCRA, cardiac rhythm abnormalities, and SCD prevalence.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Therapeutic Targeting of the GSK3 beta-CUGBP1 Pathway in Myotonic Dystrophy

Maggie Lutz, Miranda Levanti, Rebekah Karns, Genevieve Gourdon, Diana Lindquist, Nikolai A. Timchenko, Lubov Timchenko

Summary: Myotonic Dystrophy type 1 (DM1) is a neuromuscular disease caused by toxic RNA with expanded CUG repeats. Correction of the GSK3 beta-CUGBP1 pathway using the GSK3 inhibitor tideglusib (TG) has shown benefits in DM1 mice. TG treatments corrected the expression of genes involved in cell transport, development, and differentiation, as well as the key trigger of myotonia in DM1. Dysregulated CUGBP1 contributes to the toxicity of expanded CUG repeats and affects gene expression and CNS abnormalities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Cell Biology

Inhibition of Postn Rescues Myogenesis Defects in Myotonic Dystrophy Type 1 Myoblast Model

Xiaopeng Shen, Zhongxian Liu, Chunguang Wang, Feng Xu, Jingyi Zhang, Meng Li, Yang Lei, Ao Wang, Chao Bi, Guoping Zhu

Summary: The research discovered that Postn gene was significantly upregulated in DM1 myogenesis, and knocking down Postn could successfully rescue myogenesis defects, suggesting that Postn could be a potential therapeutic target for treating myogenesis defects in DM1.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Endocrine Dysfunction in Patients With Myotonic Dystrophy

Stephen J. Winters

Summary: Myotonic dystrophy is a dominantly inherited multisystem disorder caused by increased CTG repeats in the DMPK gene, affecting various organs such as muscles and endocrine glands, leading to a range of complications.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cardiac Pathology in Myotonic Dystrophy Type 1

Mani S. Mahadevan, Ramesh S. Yadava, Mahua Mandal

Summary: DM1 is a multi-systemic disorder affecting various organs, with the heart being one of the most severely impacted. Cardiac conduction defects and arrhythmias are common in adults with DM1, leading to potential sudden death. Understanding of cardiac pathology in DM1 is still limited, with cardiac magnetic resonance imaging (CMR) emerging as a valuable biomarker.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Letter Clinical Neurology

CBD diagnostic criteria: exclusions as important as inclusions

Irene Litvan, Anthony E. Lang, Melissa Armstrong

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

添加到收藏夹

Article Clinical Neurology

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

Eva-Juliane Vollstedt, Susen Schaake, Katja Lohmann, Shalini Padmanabhan, Alexis Brice, Suzanne Lesage, Christelle Tesson, Marie Vidailhet, Isabel Wurster, Faycel Hentati, Anat Mirelman, Nir Giladi, Karen Marder, Cheryl Waters, Stanley Fahn, Meike Kasten, Norbert Bruggemann, Max Borsche, Tatiana Foroud, Eduardo Tolosa, Alicia Garrido, Grazia Annesi, Monica Gagliardi, Maria Bozi, Leonidas Stefanis, Joaquim J. Ferreira, Leonor Correia Guedes, Micol Avenali, Simona Petrucci, Lorraine Clark, Ekaterina Y. Fedotova, Natalya Y. Abramycheva, Victoria Alvarez, Manuel Menendez-Gonzalez, Silvia Jesus Maestre, Pilar Gomez-Garre, Pablo Mir, Andrea Carmine Belin, Caroline Ran, Chin-Hsien Lin, Ming-Che Kuo, David Crosiers, Zbigniew K. Wszolek, Owen A. Ross, Joseph Jankovic, Kenya Nishioka, Manabu Funayama, Jordi Clarimon, Caroline H. Williams-Gray, Marta Camacho, Mario Cornejo-Olivas, Luis Torres-Ramirez, Yih-Ru Wu, Guey-Jen Lee-Chen, Ana Morgadinho, Teeratorn Pulkes, Pichet Termsarasab, Daniela Berg, Gregor Kuhlenbaumer, Andrea A. Kuhn, Friederike Borngraeber, Giuseppe de Michele, Anna De Rosa, Alexander Zimprich, Andreas Puschmann, George D. Mellick, Jolanta Dorszewska, Jonathan Carr, Rosangela Ferese, Stefano Gambardella, Bruce Chase, Katerina Markopoulou, Wataru Satake, Tatsushi Toda, Malco Rossi, Marcelo Merello, Timothy Lynch, Diana A. Olszewska, Shen-Yang Lim, Azlina Ahmad-Annuar, Ai Huey Tan, Bashayer Al-Mubarak, Hasmet Hanagasi, Dariusz Koziorowski, Sibel Ertan, Gencer Genc, Patricia de Carvalho Aguiar, Melinda Barkhuizen, Marcia M. G. Pimentel, Rachel Saunders-Pullman, Bart van de Warrenburg, Susan Bressman, Mathias Toft, Silke Appel-Cresswell, Anthony E. Lang, Matej Skorvanek, Agnita J. W. Boon, Rejko Kruger, Esther M. Sammler, Vitor Tumas, Bao-Rong Zhang, Gaetan Garraux, Sun Ju Chung, Yun Joong Kim, Juliane Winkelmann, Carolyn M. Sue, Eng-King Tan, Joana Damasio, Peter Klivenyi, Vladimir S. Kostic, David Arkadir, Mika Martikainen, Vanderci Borges, Jens Michael Hertz, Laura Brighina, Mariana Spitz, Oksana Suchowersky, Olaf Riess, Parimal Das, Brit Mollenhauer, Emilia M. Gatto, Maria Skaalum Petersen, Nobutaka Hattori, Ruey-Meei Wu, Sergey N. Illarioshkin, Enza Maria Valente, Jan O. Aasly, Anna Aasly, Roy N. Alcalay, Avner Thaler, Matthew J. Farrer, Kathrin Brockmann, Jean-Christophe Corvol, Christine Klein

Summary: Through a worldwide online survey, we established an international cohort of individuals with PD-linked variants, providing harmonized and quality-controlled clinical and genetic data for each participant and promoting collaboration among researchers in the field of monogenic PD.

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

A KMT2B Frameshift Variant Causing Focal Dystonia Restricted to the Oromandibular Region After Long-Term Follow-up

Alfand Marl F. Dy Closas, Katja Lohmann, Ai Huey Tan, Norlinah Mohamed Ibrahim, Jia Lun Lim, Yi Wen Tay, Kalai Arasu Muthusamy, Azlina Binti Ahmad-Annuar, Christine Klein, Shen -Yang Lim

Summary: KMT2B-linked dystonia (DYT-KMT2B) is a childhood-onset dystonia syndrome that commonly progresses from the lower limbs to the upper limbs and eventually affects the craniocervical region. It is now recognized as one of the more common monogenic causes of dystonia syndromes. This report presents an atypical case of DYT-KMT2B with oromandibular dystonia as the initial symptom, which remained localized to this region for three decades. This is the first reported case of DYT-KMT2B from Southeast Asia and provides further evidence for the pathogenic impact of the KMT2B c.6210_6213delTGAG variant.

JOURNAL OF MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Distinguishing functional from primary tics: a study of expert video assessments

Antigony Rigas, Tina Mainka, Tamara Pringsheim, Alexander Muenchau, Irene Malaty, Yulia Worbe, Andrea E. Cavanna, Andrew John Lees, Anthony E. Lang, Davide Martino, Christos Ganos

Summary: This study revealed that the diagnostic distinction between primary and functional tics is often difficult, even for expert clinicians, in the absence of clinical information.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

添加到收藏夹

Article Clinical Neurology

The Lessebo Effect in Disease Modification Trials in Parkinson's Disease

Tiago A. Mestre, Michael P. McDermott, Raquel Lobo, Joaquim J. Ferreira, Anthony E. E. Lang

Summary: This study evaluated the "lessebo effect" in disease modification trials in Parkinson's disease and found that it did not exist in these trials. However, the use of placebo instead of an active comparator was a limitation. Prospective measurement of expectation of benefit could help assess the various impacts of placebo use.

MOVEMENT DISORDERS (2023)

添加到收藏夹

Letter Clinical Neurology

Targeting alpha-Synuclein: A Further Viewpoint

Anthony E. Lang

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Expanding the DARS phenotype: Late-adult onset myelopathy and leukoencephalopathy

Ai Huey-Tan, Adeline Su Lyn Ng, Norlisah Mohd Ramli, Weng Khong Lim, Peng Loon Cheah, Jing Xian Teo, Jyn Ling Kuan, Yi Jayne Tan, Jia Lun Lim, Elaine Guo Yan Chew, Jia Nee Foo, Khean Jin Goh, Eng-King Tan, Shen-Yang Lim

Summary: Despite extensive evaluation, many adult-onset neurological disorders still lack definitive diagnosis. This case study reports for the first time a late-onset HBSL patient with video documentation and six-year clinical follow-up. The findings highlight the importance of considering HBSL/DARS mutations in the differential diagnosis of adult-onset spastic paraplegia and/or leukoencephalopathy.

NEUROLOGY ASIA (2023)

添加到收藏夹

Article Clinical Neurology

Classification and staging of Parkinson's disease using video-based eye tracking

Donald C. Brien, Heidi C. Riek, Rachel Yep, Jeff Huang, Brian Coe, Corson Areshenkoff, David Grimes, Mandar Jog, Anthony Lang, Connie Marras, Mario Masellis, Paula McLaughlin, Alicia Peltsch, Angela Roberts, Brian Tan, Derek Beaton, Wendy Lou, Richard Swartz, Douglas P. Munoz

Summary: A simple and non-invasive test was developed using video-based eye tracking and machine learning, which showed high sensitivity in detecting the stages of Parkinson's Disease and cognitive impairment. The classifier reached a sensitivity of 83% and a specificity of 78%.

PARKINSONISM & RELATED DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

New insights from a multi-ethnic Asian progressive supranuclear palsy cohort

Shen -Yang Lim, Alfand Marl F. Dy Closas, Ai Huey Tan, Jia Lun Lim, Yi Jayne Tan, Yuganthini Vijayanathan, Yi Wen Tay, Raihanah Binti Abdul Khalid, Wai Keong Ng, Ruban Kanesalingam, Pablo Martinez -Martin, Azlina Ahmad Annuar, Lei Cheng Lit, Jia Nee Foo, Weng Khong Lim, Adeline Su Lyn Ng, Eng-King Tan

Summary: This study aimed to investigate the clinical features and disease burden of progressive supranuclear palsy (PSP) in an Asian population. The study found significant heterogeneity in PSP characteristics and burden, as well as a high prevalence of RBD symptoms, visual hallucinations, and familial involvement in Asian PSP patients. The findings highlight important considerations when assessing Asian patients and support the notion of overlapping neurobiology between PSP and Lewy body disorders.

PARKINSONISM & RELATED DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

From parasomnia to agrypnia excitata-An illustrative case on diagnostic approach

Si -Lei Fong, Alfand Marl F. Dy Closas, Thien Thien Lim, Phooi Leng Lean, Ee Chin Loh, Shen-Yang Lim, Ai Huey Tan

Summary: The article discusses the diagnostic approach to sleep-related movement disorders, with a case report of a patient with fatal familial insomnia who initially presented with persistent limb movements in sleep, which later progressed to a state of agrypnia excitata. The evaluation of abnormal movements in sleep is discussed using a step-by-step diagnostic approach. Although no cure is available for fatal familial insomnia, prompt recognition of this condition is important to facilitate proper management, including the involvement of interdisciplinary neuropalliative care.

PARKINSONISM & RELATED DISORDERS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

South Asian medical cohorts reveal strong founder effects and high rates of homozygosity

Jeffrey D. Wall, J. Fah Sathirapongsasuti, Ravi Gupta, Asif Rasheed, Radha Venkatesan, Saurabh Belsare, Ramesh Menon, Sameer Phalke, Anuradha Mittal, John Fang, Deepak Tanneeru, Manjari Deshmukh, Akshi Bassi, Jacqueline Robinson, Ruchi Chaudhary, Sakthivel Murugan, Zameer ul-Asar, Imran Saleem, Unzila Ishtiaq, Areej Fatima, Saqib Shafi Sheikh, Shahid Hameed, Mohammad Ishaq, Syed Zahed Rasheed, Fazal-ur-Rehman Memon, Anjum Jalal, Shahid Abbas, Philippe Frossard, Christian Fuchsberger, Lukas Forer, Sebastian Schoenherr, Qixin Bei, Tushar Bhangale, Jennifer Tom, Santosh Gopi Krishna Gadde, B. Priya, Naveen Kumar Naik, Minxian Wang, Pui-Yan Kwok, Amit V. Khera, B. R. Lakshmi, Adam S. Butterworth, Rajiv Chowdhury, John Danesh, Emanuele di Angelantonio, Aliya Naheed, Vinay Goyal, Rukmini M. Kandadai, Hrishikesh Kumar, Rupam Borgohain, Adreesh Mukherjee, Pettarusp M. Wadia, Ravi Yadav, Soaham Desai, Niraj Kumar, Atanu Biswas, Pramod Kumar Pal, Uday B. Muthane, Shymal K. Das, Vedam L. Ramprasad, Prashanth L. Kukkle, Somasekar Seshagiri, Sekar Kathiresan, Arkasubhra Ghosh, V. Mohan, Danish Saleheen, Eric W. Stawiski, Andrew S. Peterson

Summary: The benefits of large-scale genetic studies for healthcare have been well-documented, but certain populations, such as those from South Asia, have been overlooked. In this study, researchers collected whole genome sequence (WGS) data from individuals in Pakistan, India, Bangladesh, as well as isolated South Asian populations. The study revealed high rates of reproductive isolation, endogamy, and consanguinity in South Asia, leading to a higher prevalence of rare homozygotes compared to outbred populations. Founder effects in South Asia make it an ideal location for population-scale genetic studies.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Clinical Neurology

Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy

Daniel G. Di Luca, Carolina Ramirez-Gomez, Jurgen Germann, Brendan Santyr, Alexandre Boutet, Luka Milosevic, Anthony E. Lang, Suneil K. Kalia, Andres M. Lozano, Alfonso Fasano

Summary: This study aimed to evaluate the safety and efficacy of deep brain stimulation on the globus pallidus pars interna and externa in MSA-P patients. The surgery did not result in major complications, but did not provide significant clinical benefit as measured by MDS-UPDRS III.

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project

Eva-Juliane Vollstedt, Harutyun Madoev, Anna Aasly, Azlina Ahmad-Annuar, Bashayer Al-Mubarak, Roy N. Alcalay, Victoria Alvarez, Ignacio Amorin, Grazia Annesi, David Arkadir, Soraya Bardien, Roger A. Barker, Melinda Barkhuizen, A. Nazli Basak, Vincenzo Bonifati, Agnita Boon, Laura Brighina, Kathrin Brockmann, Andrea Carmine Belin, Jonathan Carr, Jordi Clarimon, Mario Cornejo-Olivas, Leonor Correia Guedes, Jean-Christophe Corvol, David Crosiers, Joana Damasio, Parimal Das, Patricia de Carvalho Aguiar, Anna De Rosa, Jolanta Dorszewska, Sibel Ertan, Rosangela Ferese, Joaquim Ferreira, Emilia Gatto, Gencer Genc, Nir Giladi, Pilar Gomez-Garre, Hasmet Hanagasi, Nobutaka Hattori, Faycal Hentati, Dorota Hoffman-Zacharska, Sergey N. Illarioshkin, Joseph Jankovic, Silvia Jesus, Valtteri Kaasinen, Anneke Kievit, Peter Klivenyi, Vladimir Kostic, Dariusz Koziorowski, Andrea A. Kuehn, Anthony E. Lang, Shen-Yang Lim, Chin-Hsien Lin, Katja Lohmann, Vladana Markovic, Mika Henrik Martikainen, George Mellick, Marcelo Merello, Lukasz Milanowski, Pablo Mir, Oezguer oeztop-cakmak, Marcia Mattos Goncalves Pimentel, Teeratorn Pulkes, Andreas Puschmann, Ekaterina Rogaeva, Esther M. Sammler, Maria Skaalum Petersen, Matej Skorvanek, Mariana Spitz, Oksana Suchowersky, Ai Huey Tan, Pichet Termsarasab, Avner Thaler, Vitor Tumas, Enza Maria Valente, Bart van de Warrenburg, Caroline H. Williams-Gray, Ruey-Mei Wu, Baorong Zhang, Alexander Zimprich, Justin Solle, Shalini Padmanabhan, Christine Klein

Summary: Parkinson's disease is a rapidly growing neurodegenerative disorder that affects approximately 7 million people worldwide. The majority of research on monogenic Parkinson's disease is focused on patients of European White ancestry, leaving a significant knowledge gap in underrepresented populations. To address this, a global network of centers working on monogenic Parkinson's disease has been established to facilitate collaborative research and the development of new therapies. An interactive map and online tool have also been developed to enable quick access to available resources and promote collaboration. This initiative aims to fill the knowledge gap and impact the treatment of monogenic and potentially idiopathic Parkinson's disease patients.

PLOS ONE (2023)

添加到收藏夹

Article Clinical Neurology

Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities

Ai Huey Tan, Mario Cornejo-Olivas, Njideka Okubadejo, Pramod Kumar Pal, Gerard Saranza, Paula Saffie-Awad, Azlina Ahmad-Annuar, Artur F. Schumacher-Schuh, Kigocha Okeng'o, Ignacio F. Mata, Emilia M. Gatto, Shen-Yang Lim

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

添加到收藏夹

Article Clinical Neurology

Estimation of Ambulation and Survival in Neurodegeneration with Brain Iron Accumulation Disorders

Elahe Amini, Mohammad Rohani, Anthony E. Lang, Zahra Azad, Seyed Amir Hassan Habibi, Afagh Alavi, Gholamali Shahidi, Maziar Emamikhah, Ahmad Chitsaz

Summary: Among 122 genetically confirmed NBIA patients, KRS had the best survival and longest preservation of ambulation ability, while classical PKAN and MPAN patients showed similar progression patterns in loss of ambulation ability, with MPAN patients having a slower progression to death. Spasticity was identified as the most significant factor associated with death.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.